The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification
Open accessAbstract
Lung cancer is the leading cause of cancer-related death worldwide due to late diagnoses and limited treatment interventions. Recently, comprehensive molecular profiles of lung cancer have been identified. These novel characteristics have enhanced the understanding of the molecular pathology of lung cancer. The identification of driver genetic alterations and potential molecular targets has resulted in molecular-targeted therapies for an increasing number of lung cancer patients. Thus, the histopathological classification of lung cancer was modified in accordance with the increased understanding of molecular profiles. This review focuses on recent developments in the molecular profiling of lung cancer and provides perspectives on updated diagnostic concepts in the new 2015 WHO classification. The WHO classification will require additional revisions to allow for reliable, clinically meaningful tumor diagnoses as we gain a better understanding of the molecular characteristics of lung cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Rizvi, N. A., Hellmann, M. D., Snyder, A., Kvistborg, P., Makarov, V., Havel, J. J., Lee, W., Yuan, J., Wong, P., Ho, T. S., et al. (2015) · Science · doi:10.1126/science.aaa1348 · Cited by 7,802
Comprehensive molecular profiling of lung adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
Soda, M., Choi, Y. L., Enomoto, M., Takada, S., Yamashita, Y., Ishikawa, S., Fujiwara, S.-I., Watanabe, H., Kurashina, K., Hatanaka, H., et al. (2007) · Nature · doi:10.1038/nature05945 · Cited by 5,439
Travis, W. D., Brambilla, E., Noguchi, M., Nicholson, A. G., Geisinger, K. R., Yatabe, Y., Beer, D. G., Powell, C. A., Riely, G. J., Van Schil, P. E., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318206a221 · Cited by 4,792
Comprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023
Shigematsu, H., Lin, L., Takahashi, T., Nomura, M., Suzuki, M., Wistuba, I. I., Fong, K. M., Lee, H., Toyooka, S., Shimizu, N., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji055 · Cited by 2,377
Comprehensive genomic profiles of small cell lung cancer
George, J., Lim, J. S., Jang, S. J., Cun, Y., Ozretić, L., Kong, G., Leenders, F., Lu, X., Fernández-Cuesta, L., Bosco, G., et al. (2015) · Nature · doi:10.1038/nature14664 · Cited by 2,340
Gene-expression profiles predict survival of patients with lung adenocarcinoma
Beer, D. G., Kardia, S. L. R., Huang, C.-C., Giordano, T. J., Levin, A. M., Misek, D. E., Lin, L., Chen, G., Gharib, T. G., Thomas, D. G., et al. (2002) · Nature Medicine · doi:10.1038/nm733 · Cited by 2,025
Travis, W. D., Brambilla, E., Burke, A. P., Marx, A., & Nicholson, A. G. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000663 · Cited by 1,905
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
Shaw, A. T., Yeap, B. Y., Mino-Kenudson, M., Digumarthy, S. R., Costa, D. B., Heist, R. S., Solomon, B., Stubbs, H., Admane, S., McDermott, U., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.6993 · Cited by 1,870
WHO classification of tumours of the lung, pleura, thymus and heart
Travis, W. D. (2015) · International Agency for Research on Cancer eBooks · Cited by 1,664
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
Peifer, M., Fernández-Cuesta, L., Sos, M. L., George, J., Seidel, D., Kasper, L. H., Plenker, D., Leenders, F., Sun, R., Zander, T., et al. (2012) · Nature Genetics · doi:10.1038/ng.2396 · Cited by 1,397
RET, ROS1 and ALK fusions in lung cancer
Takeuchi, K., Soda, M., Togashi, Y., Suzuki, R., Sakata, S., Hatano, S., Asaka, R., Hamanaka, W., Ninomiya, H., Uehara, H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2658 · Cited by 1,320
Small adenocarcinoma of the lung. Histologic characteristics and prognosis
Noguchi, M., Morikawa, A., Kawasaki, M., Matsuno, Y., Yamada, T., Hirohashi, S., Kondo, H., & Shimosato, Y. (1995) · Cancer · doi:10.1002/1097-0142(19950615)75:12<2844::aid-cncr2820751209>3.0.co;2-# · Cited by 1,134
Rudin, C. M., Durinck, S., Stawiski, E. W., Poirier, J. T., Modrusan, Z., Shames, D. S., Bergbower, E. A., Guan, Y., Shin, J., Guillory, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2405 · Cited by 1,077
KIF5B-RET fusions in lung adenocarcinoma
Kohno, T., Ichikawa, H., Totoki, Y., Yasuda, K., Hiramoto, M., Nammo, T., Sakamoto, H., Tsuta, K., Furuta, K., Shimada, Y., et al. (2012) · Nature Medicine · doi:10.1038/nm.2644 · Cited by 834
Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer
Vaishnavi, A., Capelletti, M., Le, A. T., Kako, S., Butaney, M., Ercan, D., Mahale, S., Davies, K. D., Aisner, D. L., Pilling, A. B., et al. (2013) · Nature Medicine · doi:10.1038/nm.3352 · Cited by 607
EML4-ALK Fusion Is Linked to Histological Characteristics in a Subset of Lung Cancers
Inamura, K., Takeuchi, K., Togashi, Y., Nomura, K., Ninomiya, H., Okui, M., Satoh, Y., Okumura, S., Nakagawa, K., Soda, M., et al. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31815e8b60 · Cited by 467
Self-citationInamura, K., Takeuchi, K., Togashi, Y., Hatano, S., Ninomiya, H., Motoi, N., Mun, M.-Y., Sakao, Y., Okumura, S., Nakagawa, K., et al. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.2 · Cited by 445
Self-citationp40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma
Bishop, J. A., Teruya-Feldstein, J., Westra, W. H., Pelosi, G., Travis, W. D., & Rekhtman, N. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.173 · Cited by 398
CD74–NRG1 Fusions in Lung Adenocarcinoma
Fernandez-Cuesta, L., Plenker, D., Osada, H., Sun, R., Menon, R., Leenders, F., Ortiz-Cuaran, S., Peifer, M., Bos, M., Daßler, J., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0633 · Cited by 294
Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
Nakaoku, T., Tsuta, K., Ichikawa, H., Shiraishi, K., Sakamoto, H., Enari, M., Furuta, K., Shimada, Y., Ogiwara, H., Watanabe, S.-I., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0107 · Cited by 206
Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung
Shim, H. S., Kenudson, M., Zheng, Z., Liebers, M., Cha, Y. J., Hoang Ho, Q., Onozato, M., Phi Le, L., Heist, R. S., & Iafrate, A. J. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000579 · Cited by 203
RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis
Tsuta, K., Kohno, T., Yoshida, A., Shimada, Y., Asamura, H., Furuta, K., & Kushima, R. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.36 · Cited by 202
MicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for Treatment
Inamura, K., & Ishikawa, Y. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5030036 · Cited by 178
Self-citationPolley, E., Kunkel, M., Evans, D., Silvers, T., Delosh, R., Laudeman, J., Ogle, C., Reinhart, R., Selby, M., Connelly, J., et al. (2016) · Journal of the National Cancer Institute · doi:10.1093/jnci/djw122 · Cited by 169
Inamura, K., Satoh, Y., Okumura, S., Nakagawa, K., Tsuchiya, E., Fukayama, M., & Ishikawa, Y. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000160438.00652.8b · Cited by 168
Self-citationROS1-Rearranged Lung Cancer: A Clinicopathologic and Molecular Study of 15 Surgical Cases
Yoshida, A., Kohno, T., Tsuta, K., Wakai, S., Arai, Y., Shimada, Y., Asamura, H., Furuta, K., Shibata, T., & Tsuda, H. (2013) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182758fe6 · Cited by 165
Association of tumor TROP2 expression with prognosis varies among lung cancer subtypes
Inamura, K., Yokouchi, Y., Kobayashi, M., Ninomiya, H., Sakakibara, R., Subat, S., Nagano, H., Nomura, K., Okumura, S., Shibutani, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15647 · Cited by 146
Self-citationmiR-375 Is Activated by ASH1 and Inhibits YAP1 in a Lineage-Dependent Manner in Lung Cancer
Nishikawa, E., Osada, H., Okazaki, Y., Arima, C., Tomida, S., Tatematsu, Y., Taguchi, A., Shimada, Y., Yanagisawa, K., Yatabe, Y., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1020 · Cited by 138
MicroRNA Targeting to Modulate Tumor Microenvironment
Kuninty, P. R., Schnittert, J., Storm, G., & Prakash, J. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00003 · Cited by 130
Inamura, K., Ninomiya, H., Ishikawa, Y., & Matsubara, O. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2008-0586-rar1.1 · Cited by 122
Self-citationInamura, K., Fujiwara, T., Hoshida, Y., Isagawa, T., Jones, M. H., Virtanen, C., Shimane, M., Satoh, Y., Okumura, S., Nakagawa, K., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208858 · Cited by 107
Self-citationA MicroRNA Cluster at 14q32 Drives Aggressive Lung Adenocarcinoma
Nadal, E., Zhong, J., Lin, J., Reddy, R. M., Ramnath, N., Orringer, M. B., Chang, A. C., Beer, D. G., & Chen, G. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3348 · Cited by 106
Correlation between morphology and EGFR mutations in lung adenocarcinomas
Ninomiya, H., Hiramatsu, M., Inamura, K., Nomura, K., Okui, M., Miyoshi, T., Okumura, S., Satoh, Y., Nakagawa, K., Nishio, M., et al. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.04.017 · Cited by 99
Self-citationKRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung
Hwang, D. H., Sholl, L. M., Rojas‐Rudilla, V., Hall, D. L., Shivdasani, P., Garcia, E. P., MacConaill, L. E., Vivero, M., Hornick, J. L., Kuo, F. C., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.01.010 · Cited by 93
Tumor B7-H3 (CD276) expression and smoking history in relation to lung adenocarcinoma prognosis
Inamura, K., Yokouchi, Y., Kobayashi, M., Sakakibara, R., Ninomiya, H., Subat, S., Nagano, H., Nomura, K., Okumura, S., Shibutani, T., et al. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.11.013 · Cited by 93
Self-citationNotch Signaling in Neuroendocrine Tumors
Crabtree, J. S., Singleton, C. S., & Miele, L. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00094 · Cited by 90
Inamura, K., Togashi, Y., Nomura, K., Ninomiya, H., Hiramatsu, M., Satoh, Y., Okumura, S., Nakagawa, K., & Ishikawa, Y. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.07.013 · Cited by 74
Self-citationInamura, K., Yokouchi, Y., Sakakibara, R., Kobayashi, M., Subat, S., Ninomiya, H., Nagano, H., Nomura, K., Okumura, S., & Ishikawa, Y. (2016) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyw087 · Cited by 58
Self-citationKim, H., Yang, J. M., Jin, Y., Jheon, S., Kim, K., Lee, C. T., Chung, J.-H., & Paik, J. H. (2016) · Oncotarget · doi:10.18632/oncotarget.14298 · Cited by 50
Plasma miR-92a-2 as a biomarker for small cell lung cancer
Yu, Y., Zuo, J., Tan, Q., Thin, K. Z., Li, P., Zhu, M., Yu, M., Fu, Z., Liang, C., & Tu, J. (2017) · Cancer Biomarkers · doi:10.3233/cbm-160254 · Cited by 46
Saruwatari, K., Ikemura, S., Sekihara, K., Kuwata, T., Fujii, S., Umemura, S., Kirita, K., Matsumoto, S., Yoh, K., Niho, S., et al. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.11.012 · Cited by 43
Recent Advances in Immunotherapy in Metastatic NSCLC
Bansal, P., Osman, D. I., Gan, G. N., Simon, G. R., & Boumber, Y. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00239 · Cited by 43
Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC
Bansal, P., Osman, D. I., Gan, G. N., Simon, G. R., & Boumber, Y. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00112 · Cited by 36
HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression
Mirzapoiazova, T., Mambetsariev, N., Lennon, F. E., Mambetsariev, B., Berlind, J. E., Salgia, R., & Singleton, P. A. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00164 · Cited by 35
Differential miRNA-Expression as an Adjunctive Diagnostic Tool in Neuroendocrine Tumors of the Lung
Demes, M. C., Aszyk, C. M., Bartsch, H., Schirren, J., & Fisseler‐Eckhoff, A. (2016) · Cancers · doi:10.3390/cancers8040038 · Cited by 34
Garajová, I., Funel, N., Fiorentino, M., Agostini, V., Ferracin, M., Negrini, M., Frassineti, G. L., Gavelli, G., Frampton, A. E., Biasco, G., et al. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0162-5 · Cited by 26
SF3A1 and pancreatic cancer: new evidence for the association of the spliceosome and cancer
Tian, J., Liu, Y., Zhu, B., Tian, Y., Zhong, R., Chen, W., Lu, X., Zou, L., Shen, N., Qian, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5647 · Cited by 21
Export of microRNAs: A Bridge between Breast Carcinoma and Their Neighboring Cells
Jahagirdar, D., Purohit, S., Jain, A. Y., & Sharma, N. K. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00147 · Cited by 18
Cited by
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Lung cancer immunotherapy: progress, pitfalls, and promises
Lahiri, A., Maji, A., Potdar, P. D., Singh, N., Parikh, P., Bisht, B., Mukherjee, A., & Paul, M. K. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01740-y · Cited by 1,102
Golding, B., Luu, A., Jones, R., & Viloria-Petit, A. M. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0810-4 · Cited by 273
Yee Kuen, C., & Masarudin, M. J. (2022) · Molecules · doi:10.3390/molecules27020473 · Cited by 78
Uncovering Prognosis-Related Genes and Pathways by Multi-Omics Analysis in Lung Cancer
Asada, K., Kobayashi, K., Joutard, S., Tubaki, M., Takahashi, S., Takasawa, K., Komatsu, M., Kaneko, S., Sese, J., & Hamamoto, R. (2020) · Biomolecules · doi:10.3390/biom10040524 · Cited by 67
Metadata
- Authors
- Inamura, K.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2017-08-28
- Volume
- 7
- Pages
- 193-193
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2748959367
- Cited by
- 503
- References
- 57
- FWCI
- 25.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.